Bio-Techne CorporationTECHNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
2.93%
↓ 69% below average
Average (9y)
9.50%
Historical baseline
Range
High:23.42%
Low:2.93%
CAGR
-13.3%
Structural decline
| Period | Value |
|---|---|
| 2025 | 2.93% |
| 2024 | 4.51% |
| 2023 | 6.14% |
| 2022 | 23.42% |
| 2021 | 8.30% |
| 2020 | 4.45% |
| 2019 | 12.80% |
| 2018 | 3.39% |
| 2017 | 18.43% |
| 2016 | 10.61% |